Published in Proc Natl Acad Sci U S A on July 01, 1991
Mechanisms of tau-induced neurodegeneration. Acta Neuropathol (2009) 2.27
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A (1996) 2.11
Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res (2010) 2.07
Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol (1992) 1.95
Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J (1993) 1.91
The role of tau in neurodegeneration. Mol Neurodegener (2009) 1.54
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A (2000) 1.47
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain (2012) 1.38
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med (2007) 1.21
Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.19
Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J (1991) 1.16
Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathol (1992) 1.12
Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol (2008) 1.11
Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. Am J Pathol (1991) 1.11
Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3. Biochem J (2003) 1.11
Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am J Pathol (1993) 1.03
Alzheimer's disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement (2010) 0.99
Microtubule-associated protein 1B (MAP1B) is required for dendritic spine development and synaptic maturation. J Biol Chem (2011) 0.95
Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis. Cell Mol Neurobiol (2006) 0.90
Developing pharmacological therapies for Alzheimer disease. Cell Mol Life Sci (2007) 0.87
Beyond the rat models of human neurodegenerative disorders. Cell Mol Neurobiol (2009) 0.86
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease. J Biol Chem (2015) 0.85
Different susceptibility to neurodegeneration of dorsal and ventral hippocampal dentate gyrus: a study with transgenic mice overexpressing GSK3β. PLoS One (2011) 0.83
Tau protein and adult hippocampal neurogenesis. Front Neurosci (2012) 0.83
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease. Alzheimers Res Ther (2014) 0.82
Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial. Biochem Soc Trans (2010) 0.82
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules (2016) 0.81
New age of neuroproteomics in Alzheimer's disease research. Cell Mol Neurobiol (2009) 0.81
Prion protein accumulation in lipid rafts of mouse aging brain. PLoS One (2013) 0.81
Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration. Cell Mol Life Sci (2014) 0.80
Microglia display modest phagocytic capacity for extracellular tau oligomers. J Neuroinflammation (2014) 0.80
Selective tau tyrosine nitration in non-AD tauopathies. Acta Neuropathol (2011) 0.80
Truncation of tau at E391 promotes early pathologic changes in transgenic mice. J Neuropathol Exp Neurol (2011) 0.79
A Simple Model to Study Tau Pathology. J Exp Neurosci (2016) 0.76
Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles. Am J Pathol (1992) 0.75
Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer's Disease. Biomolecules (2016) 0.75
Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol Dis (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem (1987) 34.69
Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci U S A (1973) 18.46
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A (1986) 10.13
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron (1989) 8.04
A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science (1991) 5.60
Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A (1988) 4.68
Paired helical filaments in electron microscopy of Alzheimer's disease. Nature (1963) 4.62
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 4.45
A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A (1990) 4.26
A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J (1990) 3.36
Epitopes that span the tau molecule are shared with paired helical filaments. Neuron (1988) 3.28
Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J Biochem (1986) 2.54
Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 2.53
The carboxyl third of tau is tightly bound to paired helical filaments. Neuron (1988) 2.31
Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am J Pathol (1990) 1.64
Alzheimer-related neuronal protein A68: specificity and distribution. Ann Neurol (1987) 1.45
Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1. J Biol Chem (1988) 1.43
Abnormal tau species are produced during Alzheimer's disease neurodegenerating process. FEBS Lett (1989) 1.41
Protease from Staphyloccus aureus. Methods Enzymol (1976) 1.31
Alz-50 recognizes a phosphorylated epitope of tau protein. J Neurosci (1990) 1.22
Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.19
Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J Neurosci Res (1990) 1.17
The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain. Neurosci Lett (1988) 1.16
A common amino acid sequence in 190-kDa microtubule-associated protein and tau for the promotion of microtubule assembly. J Biol Chem (1989) 1.15
Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease. J Neurochem (1989) 1.12
A distinct form of tau is selectively incorporated into Alzheimer's paired helical filaments. Biochem Biophys Res Commun (1989) 1.09
The repeat region of microtubule-associated protein tau forms part of the core of the paired helical filament of Alzheimer's disease. Ann Med (1989) 1.04
Gas-phase sequencing after electroblotting on polyvinylidene difluoride membranes assigns correct molecular weights to myoglobin molecular weight markers. Anal Biochem (1989) 1.03
Characterisation of the first monoclonal antibody against the pronase resistant core of the Alzheimer PHF. Prog Clin Biol Res (1989) 1.00
Reassessment of commercially available molecular weight standards for peptide sodium dodecyl sulfate-polyacrylamide gel electrophoresis using electroblotting and microsequencing. Electrophoresis (1990) 0.97
Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol (1990) 0.96
Competitive ELISA for the measurement of tau protein in Alzheimer's disease. J Immunol Methods (1990) 0.95
Peptides corresponding to the second repeated sequence in MAP-2 inhibit binding of microtubule-associated proteins to microtubules. Biochemistry (1990) 0.93
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
Increased tau messenger RNA in Alzheimer's disease hippocampus. Am J Pathol (1990) 0.81
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol (1976) 30.70
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature (1977) 16.54
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell (1978) 14.82
Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol (1981) 14.45
A possible precursor of immunoglobulin light chains. Nat New Biol (1972) 11.03
Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol (1979) 10.51
Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line. J Cell Biol (1982) 9.66
Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell (1977) 8.46
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41
Complete sequence of constant and 3' noncoding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing. Cell (1978) 8.20
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron (1989) 8.04
Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol (1976) 7.64
Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature (1979) 5.69
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J Immunol (1978) 5.35
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A (1988) 4.68
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 4.45
Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. Nature (1984) 4.45
Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev (1987) 4.16
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature (1996) 4.12
Man-made antibodies. Nature (1991) 3.88
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A (2000) 3.86
Cingulin, a new peripheral component of tight junctions. Nature (1988) 3.81
Origin of antibody variation. Nature (1966) 3.50
Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron (1993) 3.45
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J (1990) 3.36
Kinetic maturation of an immune response. Nature (1991) 3.26
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett (1998) 3.26
T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody. J Exp Med (1978) 3.20
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett (1995) 3.15
Linked groups of residues in immunoglobulin k chains. Nature (1967) 3.12
Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell (1994) 3.06
The complete amino acid sequence of a mouse kappa light chain. Biochem J (1972) 2.94
Molecular events during maturation of the immune response to oxazolone. Nature (1985) 2.78
Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet (1994) 2.74
mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification. Nature (1983) 2.72
Structural studies of immunoglobulin G. Nature (1969) 2.63
Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. J Mol Biol (1968) 2.57
Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 2.53
An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing. Nature (1980) 2.41
Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem (1998) 2.32
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Hybrid hybridomas and their use in immunohistochemistry. Nature (1983) 2.24
Sequence analysis of immunoglobulin light chain messenger RNA. Nature (1974) 2.22
A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature (1986) 2.22
Active site titration and aminoacyl adenylate binding stoichiometry of aminoacyl-tRNA synthetases. Biochemistry (1975) 2.18
Detection of substance P in the central nervous system by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.16
Complete sequence of an immunoglobulin mRNA using specific priming and the dideoxynucleotide method of RNA sequencing. Nucleic Acids Res (1981) 2.16
Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. J Mol Biol (1974) 2.14
Variations in amino-acid sequence near the disulphide bridges of Bence-Jones proteins. Nature (1966) 2.14
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell (1990) 2.12
Human immunoglobulin subclasses. Partial amino acid sequence of the constant region of a gamma 4 chain. Biochem J (1970) 2.11
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A (1996) 2.11
Two classes of CD1 genes. Eur J Immunol (1989) 2.11
Structure and biological properties of immunoglobulins. Adv Immunol (1967) 2.08
The dynamic nature of the antibody repertoire. Immunol Rev (1988) 2.08
Somatic hypermutation. Curr Opin Immunol (1995) 2.08
Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol (1985) 2.06
The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A (1993) 1.99
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A (2001) 1.99
Conformational isomerism and the diversity of antibodies. Proc Natl Acad Sci U S A (1994) 1.99
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease. J Neurosci Res (2000) 1.97
Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell (1978) 1.97
Original and artificial antibodies. Nature (1992) 1.97
Structure and evolution of immunoglobulins. Prog Biophys Mol Biol (1970) 1.96
Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today (1993) 1.93
Reshaping human antibodies: grafting an antilysozyme activity. Science (1988) 1.92
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J (1993) 1.91
Three rat monoclonal antibodies to human C3. Immunology (1980) 1.91
Molecular analysis of spontaneous somatic mutants. Nature (1977) 1.90
The disulphide bridges of immunoglobulin kappa-chains. Biochem J (1966) 1.89
Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis. Cell (1996) 1.88
Low cytoplasmic mRNA levels of immunoglobulin kappa light chain genes containing nonsense codons correlate with inefficient splicing. EMBO J (1994) 1.87
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J (1994) 1.85
Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol (1994) 1.84
The amino acid sequence around the reactive serine residue in alkaline phosphatase from Escherichia coli. Biochem J (1964) 1.83
Letter: Fusion of two immunoglobulin-producing myeloma cells. Nature (1973) 1.83
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J (1991) 1.83
Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J (1987) 1.82
Image reconstruction of the Alzheimer paired helical filament. EMBO J (1985) 1.82
Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J Immunol (2005) 1.80
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80
Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett (1998) 1.79
Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J (1995) 1.77
The primary structure of alamethicin. Biochem J (1970) 1.77
Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci U S A (1986) 1.77
Affinity maturation leads to differential expression of multiple copies of a kappa light-chain transgene. Nature (1993) 1.75
Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature (1990) 1.74
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A (1994) 1.74
Villin sequence and peptide map identify six homologous domains. Proc Natl Acad Sci U S A (1988) 1.71
Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum. J Cell Biol (1991) 1.70
Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem (1995) 1.70